Searching News Database: Abingworth
HSMN NewsFeed - 30 Apr 2018
Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough
Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough
HSMN NewsFeed - 23 May 2017
IFM Therapeutics Appoints H. Martin Seidel as Executive Vice President of Research and Development
IFM Therapeutics Appoints H. Martin Seidel as Executive Vice President of Research and Development
HSMN NewsFeed - 3 May 2017
GammaDelta Therapeutics Expands Management Team Led by Paolo Paoletti as CEO
GammaDelta Therapeutics Expands Management Team Led by Paolo Paoletti as CEO
HSMN NewsFeed - 22 Jun 2016
IFM Therapeutics Raises $27 Million Series A Financing Led by Atlas Venture and Abingworth
IFM Therapeutics Raises $27 Million Series A Financing Led by Atlas Venture and Abingworth
HSMN NewsFeed - 22 Jul 2015
Wilson Therapeutics Announces the Appointment of Dr. Carl Bjartmar as Chief Medical Officer
Wilson Therapeutics Announces the Appointment of Dr. Carl Bjartmar as Chief Medical Officer
HSMN NewsFeed - 7 Jul 2015
Abingworth Appoints Tim Haines and Kurt von Emster as Joint Managing Partners
Abingworth Appoints Tim Haines and Kurt von Emster as Joint Managing Partners
HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
HSMN NewsFeed - 5 Feb 2013
FDA Clears Sculptor Robotic Guidance Arm(TM) for Unicompartmental Knee Replacement Surgery
FDA Clears Sculptor Robotic Guidance Arm(TM) for Unicompartmental Knee Replacement Surgery
HSMN NewsFeed - 9 Oct 2012
Cytos Biotechnology Ltd appoints Dr. Christian Itin as Chief Executive Officer
Cytos Biotechnology Ltd appoints Dr. Christian Itin as Chief Executive Officer
HSMN NewsFeed - 15 May 2012
Sonitus Medical Closes $25 Million Series D Round Of Venture Capital Financing
Sonitus Medical Closes $25 Million Series D Round Of Venture Capital Financing
HSMN NewsFeed - 6 Jan 2011
Gynesonics Receives the CE-Mark for the VizAblate(TM) System to Treat Uterine Fibroids
Gynesonics Receives the CE-Mark for the VizAblate(TM) System to Treat Uterine Fibroids
HSMN NewsFeed - 13 Jul 2010
Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
HSMN NewsFeed - 6 Apr 2010
IMI Intelligent Medical Implants Names Robert J. Rosenthal Chief Executive Officer
IMI Intelligent Medical Implants Names Robert J. Rosenthal Chief Executive Officer
HSMN NewsFeed - 2 Dec 2009
Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman
Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman
HSMN NewsFeed - 10 Feb 2009
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
HSMN NewsFeed - 4 Dec 2008
Broncus Technologies Secures $38 Million in Funding Round Led by Ares Life Sciences
Broncus Technologies Secures $38 Million in Funding Round Led by Ares Life Sciences
HSMN NewsFeed - 21 Jul 2008
IMI Intelligent Medical Implants AG Announces the Appointment Robert J. Hill as Vice President of Operations
IMI Intelligent Medical Implants AG Announces the Appointment Robert J. Hill as Vice President of Operations
HSMN NewsFeed - 5 Nov 2007
Synosia Therapeutics Announces Appointment of Vice President of Clinical Research and Development
Synosia Therapeutics Announces Appointment of Vice President of Clinical Research and Development
HSMN NewsFeed - 7 May 2007
Portola Pharmaceuticals, Inc. Announces Completion of $70 Million Series C Financing
Portola Pharmaceuticals, Inc. Announces Completion of $70 Million Series C Financing
HSMN NewsFeed - 5 Dec 2006
Indevus and Sanofi-Aventis' Spin-Out Company, Novexel, Announce Out-licensing of Aminocandin Anti-fungal
Indevus and Sanofi-Aventis' Spin-Out Company, Novexel, Announce Out-licensing of Aminocandin Anti-fungal
HSMN NewsFeed - 1 Jun 2006
Ablynx Strengthens Management Team - Eva-Lotta Allan Joins as Chief Business Officer
Ablynx Strengthens Management Team - Eva-Lotta Allan Joins as Chief Business Officer
Additional items found! 11
Members Archive contains
11 additional stories matching:
Abingworth
(Password required)
Abingworth
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!